Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma

Table 2

Relationship between miR-210 expression and clinical characteristics.

Clinical characteristics	miR-210 expression
	Ad cases		Sq cases
Gender		0.086		1.000
Male	2.32 ± 2.89		2.88 ± 2.00
Female	1.45 ± 1.67		2.93 ± 0.88
Age		0.029		—
≤65	1.18 ± 1.71		—
≥66	2.17 ± 2.60		2.87 ± 1.89
Tumor size		0.402		1.000
<30 mm	1.84 ± 1.95		2.87 ± 1.62
≥30 mm	1.87 ± 2.98		3.25 ± 2.14
Histology		—		—
Adeno	1.86 ± 2.40		—
Squamous	—		2.87 ± 1.89
T factor		0.417		1.000
T1-T2	1.82 ± 2.48		2.88 ± 1.65
T3-T4	2.34 ± 1.70		3.37 ± 4.40
Lymph node		0.034		—
Negative	1.44 ± 2.01		2.87 ± 1.89
Positive	2.34 ± 2.97		—
P-stage		0.019		1.000
Stage I	1.37 ± 2.02		2.88 ± 1.65
Stages II-III	2.62 ± 2.77		3.37 ± 4.40
ly factor		0.025		0.620
Negative	1.23 ± 1.44		3.30 ± 2.07
Positive	2.24 ± 2.84		2.09 ± 1.23
v factor		0.097		1.000
Negative	1.75 ± 1.97		2.12 ± 1.84
Positive	2.34 ± 2.98		3.01 ± 1.86
Relapse		0.007		1.000
With	2.72 ± 2.63		2.88 ± 1.96
Without	1.35 ± 1.75		2.87 ± 1.84

Ad: adenocarcinoma.
Sq: squamous cell carcinoma.
Relapse was defined as first evidence of radiographic metastatic disease after surgery.
< 0.05.